IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab ...

Cox, Castle & Nicholson LLP, a leading full-service law firm specializing in real estate in the United States, announced ...

Under the liquidity contract entrusted by Medincell (Paris:MEDCL) to Rothschild Martin Maurel, the following resources were ...

Genentech will more than double the initial investment in a state-of-the-art biomanufacturing facility in Holly Springs to approximately $2 billion, bolstering Roche and Genentech’s $50 billion ...

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San ...

Agreement comes on the heels of Company inking an exclusive distribution agreement with Gulf Medical for Saudi ArabiaCreates ...

Davos: Investing in small scale farmers and rural entrepreneurs is a compelling business case and a geostrategic ...

Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), ...

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and ...

Oral presentation to highlight first-ever clinical evidence supporting use of a targeted GYS1 substrate reduction therapy, ...

Sixth overall for Lantern’s A.I.-driven precision oncology pipelineOrphan designation expands LP-284's potential for an ...

AI-enhanced intellectual property search solution simplifies complex research and expands curated content accessCOLUMBUS, ...